Loss to follow‐up in an international, multicentre observational study

The aim of this work was to assess loss to follow‐up (LTFU) in EuroSIDA, an international multicentre observational cohort study.

[1]  The Swiss Hiv Cohort Study,et al.  The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics , 2005, Sozial- und Präventivmedizin.

[2]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.

[3]  A. Gifford,et al.  Participation in research and access to experimental treatments by HIV-infected patients. , 2002, The New England journal of medicine.

[4]  JD Lundgren,et al.  Changing patterns of mortality across Europe in patients infected with HIV-1 , 1998, The Lancet.

[5]  P. Wright,et al.  Antiretroviral therapy in a thousand patients with AIDS in Haiti. , 2005, The New England journal of medicine.

[6]  G. Harms,et al.  Risk factors for treatment denial and loss to follow‐up in an antiretroviral treatment cohort in Kenya , 2007, Tropical medicine & international health : TM & IH.

[7]  Administrador Opimec.  Hospital Germans Trias i Pujol , 2009 .

[8]  J. Palensky,et al.  A national HIV community cohort: design, baseline, and follow-up of the AmFAR Observational Database. American Foundation for AIDS Research Community-Based Clinical Trials Network. , 1998, Journal of clinical epidemiology.

[9]  H. Lane,et al.  The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. , 2002, Controlled clinical trials.

[10]  R. Salamon,et al.  Impact of Vital Status Investigation Procedures on Estimates of Survival in Cohorts of HIV-Infected Patients From Sub-Saharan Africa , 2004, Journal of acquired immune deficiency syndromes.

[11]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[12]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[13]  A. Mocroft,et al.  Decline in the AIDS and death rates in the EuroSIDA study: an observational study , 2003, The Lancet.

[14]  A. Mocroft,et al.  Participation in clinical studies among patients infected with HIV‐1 in a single treatment centre over 12 years , 2000, HIV medicine.

[15]  Richard D Moore,et al.  Interval and clinical cohort studies: epidemiological issues. , 2007, AIDS research and human retroviruses.

[16]  J Darbyshire,et al.  CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.

[17]  Manuel Battegay,et al.  Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study , 1997, BMJ.